查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1848562

新生兒加護治療呼吸器市場按產品類型、技術、模式、最終用戶和應用分類－2025-2032年全球預測

Neonatal Intensive Care Respiratory Devices Market by Product Type, Technology, Mode, End User, Application - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，新生兒加護治療呼吸設備市場規模將成長 69.8 億美元，複合年成長率為 13.94%。

主要市場統計數據
基準年 2024 24.5億美元
預計年份：2025年 28億美元
預測年份：2032年 69.8億美元
複合年成長率 (%) 13.94%

建構一個框架，用於闡述臨床需求、創新和採購需求在新生兒呼吸設備採用過程中的策略交會點。

新生兒加護治療中的呼吸設備格局正處於迫切的臨床需求、快速的技術創新和不斷演變的護理模式的交匯點。新生兒醫學的進步提高了低出生體重兒的存活率，並提升了精準呼吸支持的重要性，這種支持需要在療效和溫和的肺保護治療之間取得平衡。同時，對以家庭為中心的照護、早期拔管通訊協定和非侵入性策略的日益重視，正在重塑新生兒科室的設備選擇、臨床管道和採購重點。

臨床醫生、臨床工程師和醫院管理人員面臨著各種複雜的設備和技術，從持續性氣陽壓呼吸器系統到高頻人工呼吸器和氧氣罩，每種設備和技術都有其獨特的操作特性和培訓要求。因此，採購者不僅要考慮臨床療效，還要考慮易用性、與監測平台的整合、耗材物流以及維護便利性。此外，監管和品質系統也日益影響設備的採用時間，要求製造商和供應商提供充分的證據、互通性和全生命週期支援。

在此背景下，市場參與企業正透過調整產品系列、採用模組化架構以及進行針對性臨床研究來應對挑戰，旨在檢驗設備在新生兒這一特殊人群中的表現。因此，有關設備採購、臨床工作流程整合和投資的策略決策取決於對設備類型、技術差異以及不斷變化的醫療服務模式的清晰理解。這種轉變為後續分析組裝，揭示了臨床需求和營運實際情況如何共同驅動新生兒呼吸照護的需求動態和策略重點。

臨床實務的模式轉移：數位整合與供應鏈韌性如何重塑產品藍圖；監管預期與競爭動態；

新生兒呼吸照護正在經歷變革時期，這場變革正在重新定義臨床實踐、產品設計和供應鏈模式。其中最顯著的變化是從以有創通氣為主的治療方式轉向更早期、更先進的非侵入性呼吸支持，這得益於設備創新，這些創新優先考慮同步性、漏氣補償和自適應控制演算法。這種轉變反映了更廣泛的臨床需求，在最大限度減少肺損傷的同時，維持足夠的氣體交換，並正在推動產品漸進式改進和顛覆性新產品的湧現。

隨著臨床實踐的不斷發展，數位化和互聯互通已成為核心差異化因素。能夠與電子健康記錄整合、提供高解析度波形分析並支援遠端參數調節的設備正日益普及，因為它們支援數據驅動的醫療服務模式，並增強臨床醫生的情境察覺。此外，模組化硬體架構和軟體升級策略使製造商能夠在無需更換硬體的情況下持續提升產品效能，從而延長產品生命週期，並為醫療系統提供更大的靈活性。

供應鏈韌性和監管複雜性是進一步的變革力量。相關人員正在努力平衡本地製造措施與國際供應商網路，以確保符合不同的管理體制，同時降低地緣政治風險和關稅的影響。同時，遠距遠端醫療、遠距培訓和雲端基礎分析的整合正在拓展新生兒呼吸護理的提供地點和方式，支持專業知識的去中心化，並使專科中心能夠將監測範圍擴展到其網路之外。這些轉變並非漸進式的；它們正在重塑競爭動態、臨床應用曲線以及醫療系統對設備供應商的期望。

評估美國關稅調整對新生兒呼吸設備採購和供應鏈策略的營運和採購影響

美國在2025年前的關稅調整為新生兒呼吸設備製造商、經銷商和採購機構帶來了新的考量。關稅調整將影響到岸成本、供應商選擇和垂直整合策略，促使企業重新評估其生產佈局和採購決策。對於依賴跨境零件流通或成品進口的跨國供應商而言，關稅可能會增加定價策略和合約談判的複雜性。

為此，一些製造商正在加速近岸外包，並尋找替代供應商，以保護淨利率並降低政策突變帶來的風險。醫療系統客戶也在重新思考其分銷模式，包括長期合約、基於價值的服務組合以及本地庫存寄售安排，以保護其客戶免受價格波動的影響。此外，醫院和專科醫療中心的採購團隊正在將關稅風險納入總體擁有成本 (TCO) 分析和供應商風險評估，提高供應鏈透明度，並探索關鍵物資的緊急計畫。

值得注意的是，關稅的影響因設備類別和組件類型而異。軟體密集、專有硬體有限的設備受到的影響可能小於依賴國際採購的專用組件的機械密集型系統。因此，相關人員正在優先考慮情境規劃、敏感度分析和合約保護，以確保在各種政策結果下都能獲得必要的新生兒呼吸技術。這些調整正在影響新生兒專案的採購計畫和資本規劃決策。

產品類型、技術模式、臨床模式、可操作的細分洞察，將最終用戶和應用與採購和臨床決策聯繫起來

關鍵的細分洞察揭示了設備選擇、臨床工作流程和採購決策如何受到產品、技術、模式、最終用戶和應用等因素的影響。根據產品類型，臨床團隊和採購負責人會評估以下設備：用於無創支持和早期呼吸穩定的持續氣道正壓通氣（CPAP）設備；用於常規有創支持的傳統人工呼吸器；用於特殊肺復張和精細新生兒肺部管理的高頻人工呼吸器；以及用於間歇性氧氣療法和對介面要求極低的氧氣罩。這些產品差異決定了臨床通訊協定、培訓、耗材庫存和維修流程。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 將人工智慧演算法整合到新生兒人工呼吸器預測管理中
  • 採用高流量氧氣鼻管系統減少早產兒的侵入性通氣
  • 開發一種可攜式新生兒人工呼吸器，使嬰兒能夠在家中獲得呼吸支持
  • 建構用於遠端監測新生兒呼吸治療的即時無線監測平台
  • 精準氧合模組的進步可最佳化新生兒呼吸結局
  • 美國FDA加速核准流程促進新生兒加護治療呼吸器創新
  • 將抗菌和生物相容性塗層整合到人工呼吸器介面中，以防止感染
  • 新生兒加護病房對環保一次性呼吸耗材的需求不斷成長
  • 為農村和醫療資源匱乏地區引入遠端醫療新生兒呼吸機
  • 用於新生兒人工呼吸器的奈米材料過濾器可改善空氣品質和安全性

第6章美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 新生兒加護治療呼吸設備市場（依產品類型分類）

  • 持續性正壓呼吸裝置
  • 傳統人工呼吸器
  • 高頻人工呼吸器
  • 氧氣罩

9. 按技術分類的新生兒加護治療呼吸器市場

  • 侵入性呼吸支持
    • 傳統機械人工呼吸器
      • 雙控通風
      • 壓力控制通氣
      • 容量控制通氣
    • 高頻振盪通氣
  • 非侵入性呼吸輔助
    • 持續性氣道正壓通氣
    • 非侵入性正壓通氣

第10章 新生兒加護治療呼吸器市場（依模式分類）

  • 雙控通風
  • 壓力控制通氣
  • 容量控制通氣

第11章 新生兒加護治療呼吸器市場（依最終用戶分類）

  • 診所
  • 醫院
  • 專業護理中心

第12章 新生兒加護治療呼吸器市場（依應用領域分類）

  • 呼吸暫停監測
  • 氧氣療法
  • 提款援助

第13章 各地區新生兒加護治療呼吸器市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 新生兒加護治療呼吸器市場（依類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國新生兒加護治療呼吸器市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Koninklijke Philips NV
    • General Electric Company
    • Dragerwerk AG & Co. KGaA
    • Medtronic plc
    • Fisher & Paykel Healthcare Corporation Limited
    • Hamilton Medical AG
    • Smiths Group plc
    • Becton, Dickinson and Company
    • ResMed Inc.
    • Natus Medical Incorporated
Product Code: MRR-925E8149CBB7

The Neonatal Intensive Care Respiratory Devices Market is projected to grow by USD 6.98 billion at a CAGR of 13.94% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 2.45 billion
Estimated Year [2025] USD 2.80 billion
Forecast Year [2032] USD 6.98 billion
CAGR (%) 13.94%

Framing the strategic intersection of clinical urgency technological innovation and procurement imperatives shaping neonatal respiratory device adoption

The neonatal intensive care landscape for respiratory devices sits at the intersection of acute clinical need, rapid technological innovation, and evolving care models. Advances in neonatal medicine have extended survival at increasingly lower gestational ages, elevating the importance of precision respiratory support that balances efficacy with gentle, lung-protective therapy. In parallel, increasing emphasis on family-centered care, early extubation protocols, and non-invasive strategies is reshaping device selection, clinical pathways, and procurement priorities across neonatal units.

Clinicians, clinical engineers, and hospital administrators face a complex array of devices and technologies, from continuous positive airway pressure systems to high-frequency ventilators and oxygen hoods, each with unique operational characteristics and training requirements. Consequently, purchasers must weigh not only clinical outcomes but also usability, integration with monitoring platforms, consumable logistics, and serviceability. Furthermore, regulatory scrutiny and quality systems increasingly influence time-to-adoption, requiring manufacturers and providers to demonstrate robust evidence, interoperability, and lifecycle support.

Against this backdrop, market participants are responding through product portfolio adaptation, modular architectures, and targeted clinical studies that seek to validate device performance in delicate neonatal populations. As a result, strategic decisions about procurement, clinical workflow integration, and investment hinge on a clear understanding of device modalities, technology differentiation, and shifting care delivery patterns. This introduction frames the subsequent analysis by highlighting how clinical imperatives and operational realities jointly drive demand dynamics and strategic priorities in neonatal respiratory care.

How clinical paradigm shifts digital integration and supply chain resilience are jointly reshaping product roadmaps regulatory expectations and competitive dynamics

The neonatal respiratory device landscape is undergoing transformative shifts that are redefining clinical practice, product design, and supply chain models. Foremost among these transformations is the migration from primarily invasive ventilation approaches toward earlier and more sophisticated non-invasive respiratory support, supported by device innovations that prioritize synchrony, leak compensation, and adaptive control algorithms. This shift reflects a broader clinical imperative to minimize lung injury while maintaining adequate gas exchange, and it has catalyzed both incremental product improvements and disruptive new entrants.

Concurrent with clinical evolution, digitalization and connectivity have become core differentiators. Devices that integrate with electronic medical records, provide high-resolution waveform analytics, and enable remote parameter adjustments are gaining traction because they support data-driven care pathways and enhance clinician situational awareness. Moreover, modular hardware architectures and software-upgrade strategies are enabling manufacturers to deliver ongoing performance enhancements without wholesale hardware replacement, thereby extending product lifecycles and offering greater flexibility to health systems.

Supply chain resilience and regulatory complexity represent additional transformative forces. Stakeholders are balancing local manufacturing initiatives with international supplier networks to mitigate geopolitical risk and tariff exposure while ensuring compliance with diverse regulatory regimes. Meanwhile, the convergence of telemedicine support, remote training, and cloud-based analytics is expanding where and how neonatal respiratory care can be delivered, supporting decentralization of expertise and enabling specialty centers to extend oversight across networks. Taken together, these shifts are not merely incremental; they are restructuring competitive dynamics, clinical adoption curves, and the expectations health systems place on device vendors.

Assessing the operational and procurement consequences of United States tariff adjustments for neonatal respiratory device sourcing and supply chain strategies

Tariff changes in the United States for the year 2025 have introduced new considerations for manufacturers, distributors, and purchasing organizations involved in neonatal respiratory devices. Tariff adjustments affect landed cost, supplier selection, and vertical integration strategies, prompting firms to re-evaluate manufacturing footprints and sourcing decisions. For multinational suppliers that rely on cross-border component flows or finished-goods imports, tariffs can increase the complexity of pricing strategies and contract negotiations.

In response, some manufacturers are accelerating nearshoring initiatives and qualifying alternate suppliers to preserve margin and reduce exposure to sudden policy shifts. Others are reassessing distribution models to insulate health system customers from abrupt price variability, offering long-term contracts, value-based service bundles, or locally stocked consignment arrangements. Additionally, procurement teams within hospitals and specialty care centers are factoring tariff risk into total cost of ownership analyses and supplier risk profiles, seeking greater transparency in supply chains and contingency planning for critical consumables.

Importantly, tariff impacts vary across device categories and component intensities. Devices with high software content and limited proprietary hardware may be less affected than mechanically intensive systems that rely on specialized components sourced internationally. Consequently, stakeholders are prioritizing scenario planning, sensitivity analyses, and contractual protections that preserve access to essential neonatal respiratory technologies under a range of policy outcomes. These adaptive measures are shaping procurement timelines and capital planning decisions across neonatal programs.

Actionable segmentation insights that link product typologies technology modalities clinical modes end users and applications to procurement and clinical decision making

Key segmentation insights reveal how device selection, clinical workflow, and purchasing decisions are shaped by distinct product, technology, mode, end user, and application considerations. Based on Product Type, clinical teams and procurement officers evaluate Continuous Positive Airway Pressure Devices for non-invasive support and early respiratory stabilization, Conventional Ventilators for routine invasive support, High-Frequency Ventilators for specialized recruitment and delicate neonatal lung management, and Oxygen Hoods for intermittent oxygen therapy and minimal interface needs. These product distinctions determine not only clinical protocols but also training, consumable inventories, and maintenance routines.

Based on Technology, market behaviors diverge between Invasive Respiratory Support and Non-Invasive Respiratory Support. Within invasive approaches, Conventional Mechanical Ventilation and High-Frequency Oscillatory Ventilation present differing technical demands and monitoring requirements. Diving deeper, Conventional Mechanical Ventilation encompasses Dual-Controlled Ventilation, Pressure Controlled Ventilation, and Volume Controlled Ventilation, each delivering distinct clinician control paradigms and safety considerations. Non-invasive alternatives include Continuous Positive Airway Pressure Therapy and Non-Invasive Positive Pressure Ventilation, which influence nursing workload, skin integrity protocols, and family interaction models.

Based on Mode, the operational profile of devices varies with Dual-Controlled Ventilation, Pressure Controlled Ventilation, and Volume Controlled Ventilation, driving differences in alarm management, clinician expertise required, and the suitability of devices for incremental weaning strategies. Based on End User, purchasing and utilization patterns differ across Clinics, Hospitals, and Specialty Care Centers, with each setting balancing capital intensity, in-house expertise, and patient acuity. Finally, based on Application, device selection is informed by clinical use cases such as Apnea Monitoring, Oxygen Therapy, and Weaning Support, which determine monitoring integrations, patient selection criteria, and protocolized care bundles. Recognizing these layered segmentation dynamics enables stakeholders to align product roadmaps, training investments, and procurement specifications with the real-world needs of neonatal care teams.

How regional healthcare maturity infrastructure and regulatory diversity shape device adoption procurement strategies and manufacturer go to market models across global regions

Regional dynamics critically influence adoption patterns, regulatory navigation, and supply chain planning for neonatal respiratory devices. In the Americas, demand drivers include advanced neonatal networks, emphasis on evidence-based protocols, and substantial capital investment capacity within tertiary hospitals and specialty centers. These factors together encourage adoption of feature-rich ventilators and integrated monitoring platforms, while payers and health systems seek demonstrable clinical and operational benefits to justify procurement decisions.

In Europe Middle East & Africa, diverse regulatory frameworks and wide variations in healthcare infrastructure create a market where modularity and serviceability are often prioritized. In higher-resourced markets within the region, integration with hospital IT systems and advanced ventilation modes are important, whereas in lower-resourced contexts, robustness, ease of maintenance, and local training support become decisive factors. As a result, manufacturers often tailor distribution models and post-sale services to accommodate this heterogeneity.

In Asia-Pacific, a combination of expanding neonatal care capacity, rapid hospital construction, and rising clinical expertise is generating demand for both high-end ventilators in tertiary centers and cost-effective, reliable devices for regional hospitals and specialty centers. Moreover, regional manufacturing initiatives and partnerships with local distributors are shaping competitive dynamics, as vendors seek to balance price sensitivity with the need for advanced features and regulatory alignment. These regional distinctions influence product positioning, go-to-market strategies, and the prioritization of clinical evidence to support adoption.

Competitive and strategic patterns among device manufacturers emphasizing clinical validation modular architectures service innovation and partnership driven go to market approaches

Insights into the competitive and strategic behavior of leading companies highlight several prevailing approaches that are shaping the neonatal respiratory device ecosystem. A primary emphasis across market leaders is clinical validation: manufacturers are investing in targeted clinical studies and post-market evidence gathering to substantiate claims about lung-protective strategies, non-invasive efficacy, and device interoperability. These evidence-generation programs are increasingly designed in collaboration with leading neonatal centers to ensure relevance and to accelerate clinician acceptance.

Another common strategy is modular product architecture that supports both hardware longevity and software-driven feature upgrades. By decoupling core ventilator platforms from optional analytics and connectivity modules, manufacturers can offer scalable solutions to diverse customers while preserving upgrade pathways. Service models are likewise evolving; companies are expanding remote diagnostics, predictive maintenance, and outcome-oriented service contracts to reduce downtime and enhance value capture.

Partnerships and distribution strategies are also notable. Several firms are deepening relationships with local service providers, clinical training organizations, and technology firms to deliver comprehensive solutions rather than standalone devices. This trend aligns with health systems' preference for vendor partnerships that reduce integration burden and support clinical pathway improvements. Finally, new entrants and adjacent-technology players are pressing incumbents on pricing and feature innovation, particularly in non-invasive support and digital analytics, intensifying competition and accelerating product differentiation.

Practical strategic priorities for manufacturers and health systems to secure clinical adoption commercial resilience and regulatory alignment in neonatal respiratory care

Industry leaders should adopt a set of actionable priorities to maintain clinical relevance, commercial resilience, and regulatory compliance. First, invest in evidence-generation efforts that closely align with clinician priorities, focusing on outcomes that matter in neonatal care such as lung-protection metrics, extubation success, and reduced length of respiratory support. By prioritizing pragmatic clinical studies and real-world data collection, organizations can shorten the time between innovation and clinical adoption.

Second, design product roadmaps around modularity and software-upgrade pathways that allow customers to scale functionality without full hardware replacement. This approach supports total cost of ownership considerations and fosters long-term relationships. Third, strengthen supply chain flexibility by qualifying secondary suppliers, exploring nearshoring or regional assembly options, and structuring contracts to mitigate tariff and logistics variability. These measures will reduce procurement friction and enhance market responsiveness.

Fourth, expand service offerings to include predictive maintenance, remote training, and analytics-enabled clinical decision support, thereby creating recurring revenue streams and deeper integration into care pathways. Fifth, tailor go-to-market strategies to regional needs: offer robust, serviceable devices and training in resource-constrained settings while emphasizing connectivity and advanced ventilation modes in well-resourced tertiary centers. Finally, engage early with regulatory authorities and clinical leaders to co-design implementation plans that address safety, interoperability, and usability, ensuring smoother product introductions and sustained clinical adoption.

A robust mixed method research approach combining clinician interviews documentary review and iterative expert validation to ensure clinically grounded operational insights

The research methodology underpinning this analysis combines primary qualitative engagement, systematic secondary review, and rigorous data validation to produce actionable insights. Primary methods included in-depth interviews with clinicians, respiratory therapists, clinical engineers, and procurement leaders across neonatal units, supplemented by structured discussions with product and regulatory leaders within manufacturing organizations. These conversations provided nuanced perspectives on clinical priorities, device usability, and procurement constraints.

Secondary methods entailed a structured review of peer-reviewed clinical literature, regulatory guidance documents, device technical specifications, and publicly available clinical study registries to map technology attributes, safety considerations, and published outcomes. In addition, device manuals and training materials were analyzed to understand consumable requirements, maintenance intervals, and staff training demands. Triangulation across these sources enabled validation of thematic findings and identification of areas requiring further primary inquiry.

Data quality assurance included cross-validation of interview insights against documentary evidence and iterative review cycles with subject-matter experts to confirm clinical interpretations and operational implications. Where divergent viewpoints emerged, follow-up inquiries were conducted to reconcile differences and to ensure that conclusions reflect a broad and representative set of practitioner experiences. This mixed-method approach supports conclusions that are both clinically grounded and operationally relevant.

Synthesis of clinical technological and commercial imperatives that determine future readiness and impact in neonatal respiratory device ecosystems

In conclusion, neonatal intensive care respiratory devices are positioned at a strategic inflection point driven by clinical priorities, technological innovation, and evolving procurement dynamics. Non-invasive strategies, advanced ventilation modes, and digital integration are converging to create new expectations for device performance, evidence, and service models. At the same time, tariff dynamics and regional heterogeneity require adaptive supply chain and go-to-market approaches that balance cost, availability, and clinical needs.

Moving forward, organizations that align product development with clinician-validated outcomes, adopt modular and upgradeable architectures, and invest in integrated service offerings will be best placed to support neonatal care teams and capture long-term value. Equally important is the ability to navigate regulatory pathways and to offer tailored solutions across diverse regional contexts. By synthesizing clinical, operational, and commercial considerations, stakeholders can make informed decisions that enhance neonatal outcomes while sustaining organizational performance.

This conclusion underscores the imperative for coordinated action across manufacturers, health systems, and policy-makers to ensure that technological advances translate into safer, more effective, and more accessible respiratory care for the smallest patients.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of artificial intelligence algorithms for predictive neonatal ventilator management
  • 5.2. Adoption of high flow nasal cannula systems to reduce invasive ventilation in preterm infants
  • 5.3. Development of portable neonatal ventilators enabling home-based respiratory support for infants
  • 5.4. Implementation of real-time wireless monitoring platforms for remote neonatal respiratory therapy oversight
  • 5.5. Advancement in precision oxygen delivery modules to optimize neonatal respiratory outcomes
  • 5.6. U.S. FDA accelerated approval pathways fueling innovation in neonatal intensive care respiratory devices
  • 5.7. Integration of antimicrobial and biocompatible coatings on ventilator interfaces to prevent infections
  • 5.8. Rising demand for eco-friendly and disposable respiratory consumables in neonatal intensive care units
  • 5.9. Emergence of telehealth-enabled neonatal respiratory devices for rural and underserved populations
  • 5.10. Use of nanomaterial-based filters in neonatal ventilators for enhanced air purity and safety

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Neonatal Intensive Care Respiratory Devices Market, by Product Type

  • 8.1. Continuous Positive Airway Pressure Devices
  • 8.2. Conventional Ventilators
  • 8.3. High-Frequency Ventilators
  • 8.4. Oxygen Hoods

9. Neonatal Intensive Care Respiratory Devices Market, by Technology

  • 9.1. Invasive Respiratory Support
    • 9.1.1. Conventional Mechanical Ventilation
      • 9.1.1.1. Dual-Controlled Ventilation
      • 9.1.1.2. Pressure Controlled Ventilation
      • 9.1.1.3. Volume Controlled Ventilation
    • 9.1.2. High-Frequency Oscillatory Ventilation
  • 9.2. Non-Invasive Respiratory Support
    • 9.2.1. Continuous Positive Airway Pressure Therapy
    • 9.2.2. Non-Invasive Positive Pressure Ventilation

10. Neonatal Intensive Care Respiratory Devices Market, by Mode

  • 10.1. Dual-Controlled Ventilation
  • 10.2. Pressure Controlled Ventilation
  • 10.3. Volume Controlled Ventilation

11. Neonatal Intensive Care Respiratory Devices Market, by End User

  • 11.1. Clinics
  • 11.2. Hospitals
  • 11.3. Specialty Care Centers

12. Neonatal Intensive Care Respiratory Devices Market, by Application

  • 12.1. Apnea Monitoring
  • 12.2. Oxygen Therapy
  • 12.3. Weaning Support

13. Neonatal Intensive Care Respiratory Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Neonatal Intensive Care Respiratory Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Neonatal Intensive Care Respiratory Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Koninklijke Philips N.V.
    • 16.3.2. General Electric Company
    • 16.3.3. Dragerwerk AG & Co. KGaA
    • 16.3.4. Medtronic plc
    • 16.3.5. Fisher & Paykel Healthcare Corporation Limited
    • 16.3.6. Hamilton Medical AG
    • 16.3.7. Smiths Group plc
    • 16.3.8. Becton, Dickinson and Company
    • 16.3.9. ResMed Inc.
    • 16.3.10. Natus Medical Incorporated

LIST OF FIGURES

  • FIGURE 1. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONTINUOUS POSITIVE AIRWAY PRESSURE DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONTINUOUS POSITIVE AIRWAY PRESSURE DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONTINUOUS POSITIVE AIRWAY PRESSURE DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONTINUOUS POSITIVE AIRWAY PRESSURE DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONTINUOUS POSITIVE AIRWAY PRESSURE DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONTINUOUS POSITIVE AIRWAY PRESSURE DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL VENTILATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL VENTILATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL VENTILATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL VENTILATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL VENTILATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL VENTILATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY HIGH-FREQUENCY VENTILATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY HIGH-FREQUENCY VENTILATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY HIGH-FREQUENCY VENTILATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY HIGH-FREQUENCY VENTILATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY HIGH-FREQUENCY VENTILATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY HIGH-FREQUENCY VENTILATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN HOODS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN HOODS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN HOODS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN HOODS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN HOODS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN HOODS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MECHANICAL VENTILATION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MECHANICAL VENTILATION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MECHANICAL VENTILATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MECHANICAL VENTILATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MECHANICAL VENTILATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MECHANICAL VENTILATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MECHANICAL VENTILATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MECHANICAL VENTILATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY DUAL-CONTROLLED VENTILATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY DUAL-CONTROLLED VENTILATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY DUAL-CONTROLLED VENTILATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY DUAL-CONTROLLED VENTILATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY DUAL-CONTROLLED VENTILATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY DUAL-CONTROLLED VENTILATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROLLED VENTILATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROLLED VENTILATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROLLED VENTILATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROLLED VENTILATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROLLED VENTILATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROLLED VENTILATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY VOLUME CONTROLLED VENTILATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY VOLUME CONTROLLED VENTILATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY VOLUME CONTROLLED VENTILATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY VOLUME CONTROLLED VENTILATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY VOLUME CONTROLLED VENTILATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY VOLUME CONTROLLED VENTILATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY HIGH-FREQUENCY OSCILLATORY VENTILATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY HIGH-FREQUENCY OSCILLATORY VENTILATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY HIGH-FREQUENCY OSCILLATORY VENTILATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY HIGH-FREQUENCY OSCILLATORY VENTILATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY HIGH-FREQUENCY OSCILLATORY VENTILATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY HIGH-FREQUENCY OSCILLATORY VENTILATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE RESPIRATORY SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE RESPIRATORY SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE RESPIRATORY SUPPORT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE RESPIRATORY SUPPORT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE RESPIRATORY SUPPORT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE RESPIRATORY SUPPORT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE RESPIRATORY SUPPORT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE RESPIRATORY SUPPORT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONTINUOUS POSITIVE AIRWAY PRESSURE THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONTINUOUS POSITIVE AIRWAY PRESSURE THERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONTINUOUS POSITIVE AIRWAY PRESSURE THERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONTINUOUS POSITIVE AIRWAY PRESSURE THERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONTINUOUS POSITIVE AIRWAY PRESSURE THERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONTINUOUS POSITIVE AIRWAY PRESSURE THERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE POSITIVE PRESSURE VENTILATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE POSITIVE PRESSURE VENTILATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE POSITIVE PRESSURE VENTILATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE POSITIVE PRESSURE VENTILATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE POSITIVE PRESSURE VENTILATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE POSITIVE PRESSURE VENTILATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY DUAL-CONTROLLED VENTILATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY DUAL-CONTROLLED VENTILATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY DUAL-CONTROLLED VENTILATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY DUAL-CONTROLLED VENTILATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY DUAL-CONTROLLED VENTILATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY DUAL-CONTROLLED VENTILATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROLLED VENTILATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROLLED VENTILATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROLLED VENTILATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROLLED VENTILATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROLLED VENTILATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROLLED VENTILATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY VOLUME CONTROLLED VENTILATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY VOLUME CONTROLLED VENTILATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY VOLUME CONTROLLED VENTILATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY VOLUME CONTROLLED VENTILATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY VOLUME CONTROLLED VENTILATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY VOLUME CONTROLLED VENTILATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY SPECIALTY CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY SPECIALTY CARE CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY SPECIALTY CARE CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY SPECIALTY CARE CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY SPECIALTY CARE CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY SPECIALTY CARE CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APNEA MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APNEA MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APNEA MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APNEA MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APNEA MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APNEA MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN THERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN THERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN THERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN THERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN THERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY WEANING SUPPORT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY WEANING SUPPORT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY WEANING SUPPORT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY WEANING SUPPORT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY WEANING SUPPORT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY WEANING SUPPORT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. AMERICAS NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 156. AMERICAS NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 157. AMERICAS NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 158. AMERICAS NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 159. AMERICAS NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 160. AMERICAS NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 161. AMERICAS NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 162. AMERICAS NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 163. AMERICAS NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MECHANICAL VENTILATION, 2018-2024 (USD MILLION)
  • TABLE 164. AMERICAS NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MECHANICAL VENTILATION, 2025-2032 (USD MILLION)
  • TABLE 165. AMERICAS NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE RESPIRATORY SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 166. AMERICAS NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE RESPIRATORY SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 167. AMERICAS NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2024 (USD MILLION)
  • TABLE 168. AMERICAS NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2025-2032 (USD MILLION)
  • TABLE 169. AMERICAS NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 170. AMERICAS NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 171. AMERICAS NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 172. AMERICAS NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. NORTH AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 176. NORTH AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 178. NORTH AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 180. NORTH AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MECHANICAL VENTILATION, 2018-2024 (USD MILLION)
  • TABLE 182. NORTH AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MECHANICAL VENTILATION, 2025-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE RESPIRATORY SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 184. NORTH AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE RESPIRATORY SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2024 (USD MILLION)
  • TABLE 186. NORTH AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2025-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 188. NORTH AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 190. NORTH AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. LATIN AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. LATIN AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 196. LATIN AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 198. LATIN AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MECHANICAL VENTILATION, 2018-2024 (USD MILLION)
  • TABLE 200. LATIN AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MECHANICAL VENTILATION, 2025-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE RESPIRATORY SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 202. LATIN AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE RESPIRATORY SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2024 (USD MILLION)
  • TABLE 204. LATIN AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2025-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 206. LATIN AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 207. LATIN AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 208. LATIN AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MECHANICAL VENTILATION, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MECHANICAL VENTILATION, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE RESPIRATORY SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE RESPIRATORY SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MECHANICAL VENTILATION, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MECHANICAL VENTILATION, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE RESPIRATORY SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE RESPIRATORY SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 245. MIDDLE EAST NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. MIDDLE EAST NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MAR